Overexpression of miR-29c downregulates hyperglycemia-induced TNF-α levels, ROS production, and increased NOX activity, thereby alleviating hyperglycemia-induced inflammation and ROS generation. The gene discussed is TNF; the disease is Hyperglycemia.